Rush University Medical Center welcomes you to Changing the Game in Lung Cancer Treatment: Precision in Medicine 2020! This two-day certified continuing medical education conference (September 15, 2020 & September 22, 2020) has been designed for healthcare providers and other clinical administrative leaders in the lung cancer space. 

Click HERE to register.

Description

Lung cancer screening and treatment have been rapidly developing since the early 2000s with ever-evolving treatment options depending on the histology, molecular profile, stage of the disease, co-morbidities, and performance status of the patient. The management and treatment options for both small cell and non-small cell lung cancer have grown to broadly include genomic testing, targeted therapies, and immunotherapy. This program will provide physicians, advanced practice providers and other healthcare professionals in the lung cancer space with vital updates in lung cancer screening and treatment.

Educational Objectives

At the conclusion of this program, attendees will be able to do the following:

1. Discuss advances and challenges in lung cancer screening.
2. Utilize mechanisms to genetically profile lung cancer and identify developments in targeted therapy.
3. Incorporate immune checkpoint inhibitors in the treatment of non-small cell lung cancer.
4. Recognize the rationale for the addition of radiation therapy to lung cancer treatment plans.
5. Identify novel advances in minimally invasive thoracic surgery and clinical trial design.

Target Audience

This activity has been planned for Physicians, Advanced Practice Nurses and other Healthcare Professionals committed to the field of Lung Cancer. 

The Conference can be accessed virtually from any location with WiFi access. Please visit www.RushLung.com to join the Conference.